# Zymeworks Inc.: financial statements, quarterly

ZYME · Nasdaq · CIK 1937653 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zyme.md) · [Financials](/companies/zyme/financials.md) · [Filings](/companies/zyme/filings.md) · [Insiders](/companies/zyme/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zyme/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.5](/filings/0001937653-24-000050.md) | [16.9 d](/filings/0001937653-26-000015.md) | [10.0](/filings/0001937653-25-000027.md) | [19.2](/filings/0001937653-25-000049.md) | [16.0](/filings/0001937653-25-000077.md) | [31.0 d](/filings/0001937653-26-000015.md) | [27.1](/filings/0001937653-26-000034.md) | [48.7](/filings/0001937653-26-000047.md) | [27.6](/filings/0001937653-25-000077.md) | [2.5 d](/filings/0001937653-26-000015.md) | [2.4](/filings/0001937653-26-000034.md) | [4.6](/filings/0001937653-26-000047.md) |
| Research and development | $m | [32.8](/filings/0001937653-23-000037.md) | [25.5 d](/filings/0001937653-24-000019.md) | [32.0](/filings/0001937653-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(33.2)](/filings/0001937653-24-000050.md) | [(23.4) d](/filings/0001937653-26-000015.md) | [(37.8)](/filings/0001937653-25-000027.md) | [(42.9)](/filings/0001937653-25-000049.md) | [(34.2)](/filings/0001937653-25-000077.md) | [(22.2) d](/filings/0001937653-26-000015.md) | [(25.6)](/filings/0001937653-26-000034.md) | [(0.7)](/filings/0001937653-26-000047.md) | [(22.1)](/filings/0001937653-25-000077.md) | [(44.2) d](/filings/0001937653-26-000015.md) | [(47.1)](/filings/0001937653-26-000034.md) | [(42.2)](/filings/0001937653-26-000047.md) |
| Income tax | $m | [1.1](/filings/0001937653-24-000050.md) | [(4.7) d](/filings/0001937653-26-000015.md) | [0.1](/filings/0001937653-25-000027.md) | [0.1](/filings/0001937653-25-000049.md) | [0.2](/filings/0001937653-25-000077.md) | [5.7 d](/filings/0001937653-26-000015.md) | [0.5](/filings/0001937653-26-000034.md) | [(0.2)](/filings/0001937653-26-000047.md) | [1.3](/filings/0001937653-25-000077.md) | [(0.3) d](/filings/0001937653-26-000015.md) | [(2.2)](/filings/0001937653-26-000034.md) | [(0.3)](/filings/0001937653-26-000047.md) |
| Net income | $m | [(28.7)](/filings/0001937653-24-000050.md) | [(14.5) d](/filings/0001937653-26-000015.md) | [(31.7)](/filings/0001937653-25-000077.md) | [(37.7)](/filings/0001937653-25-000077.md) | [(29.9)](/filings/0001937653-25-000077.md) | [(23.5) d](/filings/0001937653-26-000015.md) | [(22.6)](/filings/0001937653-26-000047.md) | [2.3](/filings/0001937653-26-000047.md) | [(19.6)](/filings/0001937653-25-000077.md) | [(41.2) d](/filings/0001937653-26-000015.md) | [(44.2)](/filings/0001937653-26-000047.md) | [(45.0)](/filings/0001937653-26-000047.md) |
| Diluted EPS | $ per share | [(0.41)](/filings/0001937653-24-000050.md) | not reported | [(0.42)](/filings/0001937653-25-000027.md) | [(0.49)](/filings/0001937653-25-000049.md) | [(0.39)](/filings/0001937653-25-000077.md) | not reported | [(0.30)](/filings/0001937653-26-000034.md) | [0.03](/filings/0001937653-26-000047.md) | [(0.26)](/filings/0001937653-25-000077.md) | not reported | [(0.59)](/filings/0001937653-26-000034.md) | [(0.62)](/filings/0001937653-26-000047.md) |
| Basic EPS | $ per share | [(0.41)](/filings/0001937653-24-000050.md) | not reported | [(0.42)](/filings/0001937653-25-000027.md) | [(0.49)](/filings/0001937653-25-000049.md) | [(0.39)](/filings/0001937653-25-000077.md) | not reported | [(0.30)](/filings/0001937653-26-000034.md) | [0.03](/filings/0001937653-26-000047.md) | [(0.26)](/filings/0001937653-25-000077.md) | not reported | [(0.59)](/filings/0001937653-26-000034.md) | [(0.62)](/filings/0001937653-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [94.3](/filings/0001937653-23-000037.md) | [158](/filings/0001937653-25-000014.md) | [115](/filings/0001937653-24-000028.md) | [71.0](/filings/0001937653-24-000041.md) | [122](/filings/0001937653-24-000050.md) | [66.1](/filings/0001937653-26-000015.md) | [76.2](/filings/0001937653-25-000027.md) | [98.3](/filings/0001937653-25-000049.md) | [64.8](/filings/0001937653-25-000077.md) | [41.2](/filings/0001937653-26-000047.md) | [244](/filings/0001937653-26-000034.md) | [179](/filings/0001937653-26-000047.md) |
| Current assets | $m | [375](/filings/0001937653-23-000037.md) | [413](/filings/0001937653-25-000014.md) | [394](/filings/0001937653-24-000028.md) | [383](/filings/0001937653-24-000041.md) | [344](/filings/0001937653-24-000050.md) | [300](/filings/0001937653-26-000015.md) | [306](/filings/0001937653-25-000027.md) | [296](/filings/0001937653-25-000049.md) | [292](/filings/0001937653-25-000077.md) | [249](/filings/0001937653-26-000047.md) | [386](/filings/0001937653-26-000034.md) | [298](/filings/0001937653-26-000047.md) |
| Total assets | $m | [556](/filings/0001937653-23-000037.md) | [581](/filings/0001937653-25-000014.md) | [554](/filings/0001937653-24-000028.md) | [516](/filings/0001937653-24-000041.md) | [487](/filings/0001937653-24-000050.md) | [463](/filings/0001937653-26-000015.md) | [426](/filings/0001937653-25-000027.md) | [408](/filings/0001937653-25-000049.md) | [397](/filings/0001937653-25-000077.md) | [347](/filings/0001937653-26-000047.md) | [478](/filings/0001937653-26-000034.md) | [397](/filings/0001937653-26-000047.md) |
| Current liabilities | $m | [72.8](/filings/0001937653-23-000037.md) | [55.8](/filings/0001937653-25-000014.md) | [56.9](/filings/0001937653-24-000028.md) | [54.7](/filings/0001937653-24-000041.md) | [83.9](/filings/0001937653-24-000050.md) | [88.3](/filings/0001937653-26-000015.md) | [65.1](/filings/0001937653-25-000027.md) | [38.5](/filings/0001937653-25-000049.md) | [42.0](/filings/0001937653-25-000077.md) | [42.3](/filings/0001937653-26-000047.md) | [35.6](/filings/0001937653-26-000034.md) | [47.2](/filings/0001937653-26-000047.md) |
| Total liabilities | $m | [132](/filings/0001937653-23-000037.md) | [116](/filings/0001937653-25-000014.md) | [116](/filings/0001937653-24-000028.md) | [109](/filings/0001937653-24-000041.md) | [120](/filings/0001937653-24-000050.md) | [124](/filings/0001937653-26-000015.md) | [101](/filings/0001937653-25-000027.md) | [73.9](/filings/0001937653-25-000049.md) | [77.2](/filings/0001937653-25-000077.md) | [78.0](/filings/0001937653-26-000047.md) | [315](/filings/0001937653-26-000034.md) | [317](/filings/0001937653-26-000047.md) |
| Shareholders' equity | $m | [424](/filings/0001937653-24-000050.md) | [465](/filings/0001937653-26-000015.md) | [438](/filings/0001937653-25-000077.md) | [406](/filings/0001937653-25-000077.md) | [367](/filings/0001937653-25-000077.md) | [339](/filings/0001937653-26-000047.md) | [325](/filings/0001937653-26-000047.md) | [335](/filings/0001937653-26-000047.md) | [320](/filings/0001937653-25-000077.md) | [269](/filings/0001937653-26-000047.md) | [164](/filings/0001937653-26-000047.md) | [80.4](/filings/0001937653-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(42.7) d](/filings/0001937653-24-000050.md) | [13.9 d](/filings/0001937653-26-000015.md) | [(37.7)](/filings/0001937653-25-000027.md) | [(25.0) d](/filings/0001937653-25-000049.md) | [(5.9) d](/filings/0001937653-25-000077.md) | [(41.5) d](/filings/0001937653-26-000015.md) | [(3.4)](/filings/0001937653-26-000034.md) | [12.1 d](/filings/0001937653-26-000047.md) | [(31.4) d](/filings/0001937653-25-000077.md) | [(10.3) d](/filings/0001937653-26-000015.md) | [(45.7)](/filings/0001937653-26-000034.md) | [(31.9) d](/filings/0001937653-26-000047.md) |
| Capital expenditure | $m | [0.9 d](/filings/0001937653-24-000050.md) | [0.4 d](/filings/0001937653-26-000015.md) | [0.2](/filings/0001937653-25-000027.md) | [0.6 d](/filings/0001937653-25-000049.md) | [0.9 d](/filings/0001937653-25-000077.md) | [0.3 d](/filings/0001937653-26-000015.md) | [0.0](/filings/0001937653-26-000034.md) | [0.5 d](/filings/0001937653-26-000047.md) | [0.4 d](/filings/0001937653-25-000077.md) | [0.6 d](/filings/0001937653-26-000015.md) | [0.2](/filings/0001937653-26-000034.md) | [0.0 d](/filings/0001937653-26-000047.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001937653-26-000015.md) | not reported | not reported | not reported | [9.4 d](/filings/0001937653-26-000015.md) | [0.0](/filings/0001937653-26-000034.md) | [0.0 d](/filings/0001937653-26-000047.md) | [16.2 d](/filings/0001937653-25-000077.md) | [25.5 d](/filings/0001937653-26-000015.md) | [76.2](/filings/0001937653-26-000034.md) | [51.9 d](/filings/0001937653-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [66.5](/filings/0001937653-23-000037.md) | [66.7](/filings/0001937653-24-000028.md) | [67.3](/filings/0001937653-24-000041.md) | [70.6](/filings/0001937653-24-000050.md) | [76.2](/filings/0001937653-25-000027.md) | [76.4](/filings/0001937653-25-000049.md) | [76.2](/filings/0001937653-25-000077.md) | [75.2](/filings/0001937653-26-000034.md) | [77.4](/filings/0001937653-26-000047.md) | [75.8](/filings/0001937653-25-000077.md) | [74.7](/filings/0001937653-26-000034.md) | [73.0](/filings/0001937653-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 70,959,241 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001937653-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.